Company

Nanosonics Limited

Headquarters: Lane Cove, NSW, Australia

Employees: 339

CEO: Mr. Michael C. Kavanagh BSc, M.B.A.

ASX: NAN +2.61%

Market Cap

A$881.8 Million

AUD as of July 1, 2024

US$587.3 Million

Market Cap History

Nanosonics Limited market capitalization over time

Evolution of Nanosonics Limited market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Nanosonics Limited

Detailed Description

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. The company offers its products primarily to sonographers, hospitals, obstetricians, and gynecologists. Nanosonics Limited was incorporated in 2000 and is headquartered in Lane Cove, Australia.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Nanosonics Limited has the following listings and related stock indices.


Stock: ASX: NAN wb_incandescent

Details

Headquarters:

14 Mars Road

Lane Cove, NSW 2066

Australia

Phone: 61 2 8063 1600

Fax: 61 2 9418 3743